Chimerix holds the potential to have the first approval of dordaviprone for treating recurrent H3 K27M mutant high-grade ...

BioMarin's gene therapy pipeline has had setbacks, including a three-year delay in US approval of Roctavian and stalled development of PKU gene therapy BMN 307 as the Food and Drug Administration ...

Once all factors were considered, DeepSeek AI arrived at a $122 price target for Palantir stock, factoring in growth ...

We believe that Arista Networks is likely to benefit from the recently announced Stargate Project. Read why ANET stock looks ...

The stock is up significantly so far in 2025 as there have been rumors of a potential DayOne IPO, though the company later ...

FRPT earnings call for the period ending December 31, 2024. Freshpet ( FRPT -19.07%) Q4 2024 Earnings Call Feb 20, 2025, 6:30 a.m. ET ...

Loop Capital has initiated coverage with a ‘Buy’ rating, with analyst Rob Sanderson setting a $141 price target, citing the ...

We assume some AUD 200 million of debt is paid off using sales proceeds, roughly half fiscal 2024 debt outstanding, leaving Healius in a net cash position. Midcycle, we forecast a dividend payout ...

Google enables marketers to target people with serious illnesses and crushing debt—against its policies—as well as the makers ...

Russia couldn't meet its targets for months after the war started, suggesting that it will need new investment to raise ...

STMicroelectronics on Thursday said it is launching a new computer chip targeting the booming market for AI data centre ...

Retail giant Walmart (WMT) is set to announce its Q4 FY25 results today. WMT stock has gained over 79% over the past year, fueled by ...